Taysha Gene Therapies, Inc. ( TSHA) - Stock Earnings
TSHA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -32.7 million USD | — USD |
| 2025Q4 | -27.9 million USD | 5.5 million USD |
| 2026Q1 | -42.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TSHA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -111.6 million USD | 15.5 million USD |
| 2024 | -89.3 million USD | 8.3 million USD |
| 2025 | -109.0 million USD | 9.8 million USD |
| 2026 Est. | — | — |
TSHA
Price: $5.50
52 week price:
Earnings Per Share: -0.38 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 1.7 billion